Search

Search Results

• Complex Karyotype in Pediatric Acute Myeloid Leukemia

  Elena Vol’fovna Fleischman, O.I. Sokova, A.V. Popa, I.I. Kalinina, L.N. Konstantinova

  151-160

  01.04.2015

• Secondary Hemophagocytic Syndrome in the Adult Patients. Literature Review and Authors’ Experience

  Vsevolod Gennad’evich Potapenko, N.A. Potikhonova, V.V. Baikov, M.B. Belogurova, I.A. Lisukov, A.V. Klimovich, S.V. Lapin, M.O. Ivanova, V.M. Kravtsova, E.I. Podol’tseva, N.V. Medvedeva, B.V. Afanas’ev

  169-184

  01.04.2015

• Complex Chromosomal Aberrations in Patients with Post-Transplantation Relapses of Acute Leukemias: Clinical and Theoretical Aspects

  Tat’yana Leonidovna Gindina, N.N. Mamaev, S.N. Bondarenko, N.V. Semenova, E.N. Nikolaeva, M.E. Vlasova, N.V. Stancheva, O.A. Slesarchuk, V.N. Vavilov, E.V. Morozova, A.L. Alyanskii, B.V. Afanas’ev

  69–77

  01.01.2015

• First Line Treatment Choice for Chronic Myelogenous Leukemia: Modeling of Clinical and Economic Factors

  Vasilii Anatol’evich Shuvaev, K.M. Abdulkadyrov, I.S. Martynkevich, M.S. Fominykh

  78–83

  01.01.2015

• Rationale for Maintenance Treatment of Patients with Acute Myeloid Leukemia below 65 Years of Age, According to Data of a Retrospective Analysis of Protocols AML-2000 and AML-2007

  S.V. Semochkin, T.N. Tolstykh, V.V. Lunin, N.K. Khuazheva, A.I. Kostin, S.A. Chernysh, M.E. Pochtar, V.L. Ivanova

  564-572

  01.10.2014

• Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes and Clinical Significance of WT1 Gene Overexpression

  N.N. Mamaev, A.V. Gorbunova, T.L. Gindina, E.V. Morozova, Ya.V. Gudozhnikova, O.A. Slesarchuk, V.N. Ovechkina, A.A. Rats, E.G. Boichenko, E.A. Ukrainchenko, V.M. Kravtsova, A.V. Evdokimov, I.M. Barkhatov, S.N. Bondarenko, B.V. Afanas’ev

  551-563

  01.10.2014

• Imatinib Generics: Myths and Reality (Literature Review and Our Experience)

  K.M. Abdulkadyrov, V.A. Shuvaev, M.S. Fominykh

  311-316

  01.07.2014

• Allogeneic Hematopoietic Stem Cell Transplantation for ALL Patients with t(12;21)(p13;q22) Translocation

  N.N. Mamaev, E.V. Semenova, N.V. Stancheva, V.A. Katerina, I.M. Barkhatov, A.V. Evdokimov, E.G. Boychenko, T.L. Gindina, V.M. Kravtsova, L.S. Zubarovskaya, B.V. Afanasyev

  327-334

  01.07.2014

• Haploidentical hematopoietic stem cell transplantation in children with acute myeloid leukemia: evolution of method and our data

  N.N. Subbotina, I.S. Dolgopolov, A.V. Popa, V.K. Boyarshinov, R.I. Pimenov, G.L. Mentkevich

  131-136

  01.04.2014

• Acute myeloid leukemias with t(7;21)(p22;q22) translocation, 5q- deletion, CD56 expression, and hemophagocytosis: case report and literature review

  N.N. Mamayev, T.L. Gindina, E.G. Boychenko, A.V. Gorbunova, V.M. Kravtsova, N.V. Stancheva, P.V. Kozhokar, O.V. Paina, L.S. Zubarovskaya, B.V. Afanasyev

  201-205

  01.04.2014

• New molecular markers of CML progression

  V.A. Misyurin, A.V. Misyurin, L.A. Kesayeva, Yu.P. Finashutina, Ye.N. Misyurina, I.N. Soldatova, A.A. Krutov, N.A. Lyzhko, T.V. Akhlynina, A.Ye. Lukina, T.I. Kolosheynova, N.V. Novitskaya, Ye.G. Arshanskaya, Ye.G. Ovsyannikova, R.A. Golubenko, V.A. Lapin, T.I. Pospelova, V.A. Tumakov, A.Yu. Baryshnikov

  206-212

  01.04.2014

• Efficacy of platelet transfusions during standard induction chemotherapy in patients with acute myeloid leukemia

  B. Davaasambuu, S.V. Gritsayev, T.V. Glazanova, S.A. Tiranova, N.A. Potikhonova, I.S. Martynkevtch, A.V. Chechetkin

  213-219

  01.04.2014

• Role of tyrosine-kinase inhibitor selectivity in development of adverse effects during treatment of chronic myeloid leukemia

  A.A. Zeifman, E.Yu. Chelysheva, A.G. Tukrina, G.G. Chilov

  16-27

  01.01.2014

• Current best options for first line treatment of chronic phase chronic myeloid leukemia

  R. Hehlmann, S. Saußele

  9-15

  01.01.2014

• Stable donor hematopoiesis reconstitution after post-transplantation relapse of acute myeloid leukemia in patient with inv(3)(q21q26), –7 and EVI1 oncogene overexpression treated by donor lymphocyte infusions and hypomethylating agents

  N.N. Mamaev, A.V. Gorbunova, T.L. Gindina, O.A. Slesarchuk, V.N. Ovechkina, S.N. Bondarenko, O.V. Goloshchapov, V.M. Kravtsova, B.V. Afanasev

  71-75

  01.01.2014

• Genfatinib® therapy for chronic-phase chronic myeloid leukemia in routine clinical practice

  T.V. Chagorova, V.V. Yablokova, P.A. Borkina, N.A. Pryanikova

  434-438

  01.10.2013

• Clinico-hematological and molecular genetic variability of acute myeloid leukemia with CD7 expression on blasts cells

  S.V. Gritsayev, Z.V. Chubukina, I.S. Martynkevich, I.I. Kostroma, T.V. Glazanova, Ye.V. Petrova, L.S. Martynenko, S.A. Tiranova, N.A. Potikhonova, I.S. Zyuzgin, L.N. Bubnova, K.M. Abdulkadyrov

  427-433

  01.10.2013

• Apoptotic markers in CD34-positive cells in acute leukemias

  Ye.N. Parovichnikova, Ye.Ye. Khodunova, I.V. Galtseva, S.М. Kulikov, V.V. Troitskaya, L.А. Kuzmina, D.V. Shcheblyakov, V.G. Savchenko

  373-378

  01.10.2013

• Hematopoietic stem cell transplantation in AML patients with t(8;21)(q22;q22) translocation

  N.N. Mamayev, A.V. Gorbunova, T.L. Gindina, I.M. Barkhatov, S.N. Bondarenko, M.Yu. Averyanova, О.V. Pirogova, O.V. Goloshchapov, Ye.V. Kondakova, B.V. Afanasyev

  439-444

  01.10.2013

• Association between HLA-DRB1 alleles and response to imatinib in chronic myeloid leukemia

  E.G. Ovsyannikova, I.L. Davydkin, E.A. Popov, L.V. Zaklyakova, B.N. Levitan

  312-317

  01.07.2013

• Immunophenotypical and cytogenetic features of tumor cells in a patient with chronic lymphocytic leukemia associated with prolonged exposure to irradiation

  S.N. Kolyubaeva, I.A. Sukhina, V.Yu. Nikitin, T.V. Isakova, A.S. Polyakov, S.N. Malakhova, L.А. Myakoshina, J.N. Vinogradova, N.V. Il’yin

  289-293

  01.07.2013

• Materials of the scientific-and-practical conference “Current issues in oncohematology. Success of Ribomustin (bendamustine) therapy for chronic lymphocytic leukemia and non-Hodgkin’s lymphomas” (February 2013, Moscow)

  337-342

  01.07.2013

• Multiple myeloma (pathogenesis, clinical features, diagnosis, differential diagnosis). Part I

  S.S. Bessmeltsev

  237-257

  01.07.2013

• The problem of adherence to therapy in chronic myeloid leukemia: understanding the patient and making a decision

  E.Yu. Chelysheva, A.V. Galaktionova, A.G. Turkina

  157-165

  01.04.2013

• Quality of life and symptom profile in patients with chronic myeloid leukemia receiving dasatinib as а second-line therapy due to intolerance or resistance to imatinib

  T.I. Ionova, D.A. Fedorenko, T.P. Nikitina, K.A. Kurbatova

  166-176

  01.04.2013

• Cytogenetic remission as an important criterion for treatment efficacy in pediatric acute myeloid leukemia

  E.W. Fleischman, O.I. Sokova, A.V. Popa, V.S. Nemirovchenko, L.N. Konstantinova, N.F. Metelkova

  148-156

  01.04.2013

• Selection of patients for iron-chelating therapy

  S.V. Gritsaev, B. Davaasambuu, N.A. Romanenko, K.M. Abdulkadyrov

  204-209

  01.04.2013

• Cardiovascular complications of chronic myeloid leukemia treated with tyrosine kinase inhibitors

  G.E. Gendlin, L.M. Makeeva, E.I. Emelina, K.V. Shuikova, G.I. Storozhakov

  78-84

  01.01.2013

• Chimerism following allogeneic hematopoietic stem cell transplantation

  O.V. Blau

  34-39

  01.01.2013

• Management of refractory acute lymphoblastic leukemia in children and adolescents: remission re-induction followed by allogeneic hematopoietic stem cell transplantation

  E.V. Semenova, N.V. Stancheva, S.N. Bondarenko, V.N. Vavilov, D.A. Bagge, O.V. Paina, S.V. Razumova, A.S. Borovkova, T.A. Bykova, A.A. Raths, L.S. Zuborovskaya, B.V. Afanasyev

  53-59

  01.01.2013

• High-risk chronic lymphocytic leukemia: history, definition, diagnosis, and management

  E.A. Nikitin, A.B. Sudarikov

  60-68

  01.01.2013

• Chronic lymphocytic leukemia and renal cell carcinoma: literature review and case reports

  B.T. Dzhumabaeva, E.A. Nikitin, I.B. Kaplanskaya, E.E. Zybunova, L.S. Biryukova

  69-74

  01.01.2013